This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. First CRISPR-Cas patent opens race to stake out intellectual property. Nat Biotechnol 32, 599–601 (2014). https://doi.org/10.1038/nbt0714-599
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0714-599
This article is cited by
-
TILLING by Sequencing (TbyS) for targeted genome mutagenesis in crops
Molecular Breeding (2017)
-
DuPont in CRISPR-Cas patent land grab
Nature Biotechnology (2016)
-
CRISPR patents to go on trial
Nature Biotechnology (2016)
-
The emerging patent landscape of CRISPR–Cas gene editing technology
Nature Biotechnology (2016)
-
Advances in genetic engineering of the avian genome: “Realising the promise”
Transgenic Research (2016)